Gilead Sciences

Open: 77.19 Close: 77.65 Change: 0.46

You don't have time to read all about Gilead Sciences. An AI summarizes all the information for you.

Are looking for the most relevant information about Gilead Sciences? Investor spend a lot of time searching for information to make investment decisions in Gilead Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, stock, quarter, price, company, treatment, and the most common words in the summary are: gilead, science, stock, job, market, gild, inc, . One of the sentences in the summary was: The company has formed a Flag And Pole pattern on the …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences Inc. stock rises monday, still underperforms market - marketwatch.com. Gileads Inc. will release third quarter 2023 financial results on Tuesday, november 7, 2023. The company has formed a Flag And Pole pattern on the daily chart.

Today's News

Gilead Sciences Inc. stock rises monday, still underperforms market - marketwatch. gilead sciences inc. stock rose monday. Gileads Inc. will release third quarter 2023 financial results on Tuesday, november 7, 2023. Gilead Sciences stock price is 77.65 USD today. The company is no longer enjoying the benefit of enormous sales for its COVID treatment Veklury. Analysts estimate an earnings decrease this quarter of$0.16 per share, a decrease next quarter of $0.00 per share and an increase next year of $1.63 per share. Gilead Sciences has formed a Flag And Pole pattern on the daily chart. It shows that the bulls are gaining some momentum. The current market price of the GileAD Sciences Stock- $74.74 Gilehad Sciences has surged for 4 consecutive trading sessions. The company has seen a long consolidation phase. Gilead Sciences stock quotes can also be displayed as NASDAQ : GILD. GileAD Sciences stock was originally listed at a price of $1.20. Gilead Sciences had 17,000 employees on December 31, 2022. At close: Oct 13, 2023, 77.65 +0.89 (1.16%) at close: October 13,2023, 4:00 PM 77.10 -0.55 (-0.71%) After-hours: Oct.13, 20 23 - 0.55. Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus (HIV), liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company recently divulged new IKZF2 degradation inducers for treatment.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

How much time have you spent trying to decide whether investing in Gilead Sciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, stock, quarter, price, company, treatment, and the most common words in the summary are: gilead, science, stock, job, market, gild, inc, . One of the sentences in the summary was: The company has formed a Flag And Pole pattern on the daily chart.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #stock #job #market #gild #inc.